Survivin: A protein with dual roles in mitosis and apoptosis

International Review of Cytology

Volumn 247, Issue , 2005, Pages 35-88

  Wheatley, Sally P ^a   McNeish, Iain A ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Cancer; Cell division; Mitosis; Survivin

Indexed keywords

PACLITAXEL; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN;

APOPTOSIS; BREAST; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CHEMOTHERAPY; CHROMOSOME; CRYSTAL STRUCTURE; DEATH; HUMAN; IMMUNOPRECIPITATION; LIFE; MEDICAL LITERATURE; MICROTUBULE; MITOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CYSTEINE PROTEINASE INHIBITORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MITOSIS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ISOFORMS; XENOPUS PROTEINS;

EID: 28844469941     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(05)47002-3     Document Type: Review

References (192)

1. Acehan D., Jiang X.J., Morgan D.G., Heuser J.E., Wang X.D., and Akey C.W. Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation Mol. Cell 9 2002 423 432
2. Adida C., Haioun C., Gaulard P., Lepage E., Morel P., Briere J., Dombret H., Reyes F., Diebold J., Gisselbrecht C., Salles G., Altieri D.C., and Molina T.J. Prognostic significance of survivin expression in diffuse large B-cell lymphomas Blood 96 2000 1921 1925
3. Ambrosini G., Adida C., and Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat. Med. 3 1997 917 921
4. Ambrosini G., Adida C., Sirugo G., and Altieri D. Induction of apoptosis and inhibition of proliferation by survivin gene targeting J. Biol. Chem. 273 1998 11177 11182
5. 1 Mol. Biol. Cell 12 2001 1315 1328
6. Andrews P.D., Knatko E., Moore W.J., and Swedlow J.R. Mitotic mechanics: The auroras come into view Curr. Opin. Cell Biol. 15 2003 672 683
7. Andrews P.D., Ovechkina Y., Morrice N., Wagenbach M., Duncan K., Wordeman L., and Swedlow J.R. Aurora B regulates MCAK at the mitotic centromere Dev. Cell 6 2004 253 268
8. Arnt C.R., Chiorean M.V., Heldebrant M.P., Gores G.J., and Kaufmann S.H. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAPI in situ J. Biol. Chem. 277 2002 44236 44243
9. Baccini V., Roy L., Vitrat N., Chagaoui H., Sabri S., Le Couedic J.-P., Debili N., Wendling F., and Vainchenker W. Role of p21Cip/Waf in cell-cycle exit of endomitotic megakaryotes Blood 98 2001 3274 3282
10. Badran A., Yoshida A., Ishikawa K., Goi T., Yamaguchi A., Ueda T., and Inuzuka M. Identification of a novel splice variant of the human anti-apoptopsis gene survivin Biochem. Biophys. Res. Commun. 314 2004 902 907
11. Banks D.P., Plescia J., Altieri D.C., Chen J., Rosenberg S.H., Zhang H., and Ng S.C. Survivin does not inhibit caspase-3 activity Blood 96 2000 4002 4003
12. Bao R., Connolly D.C., Murphy M., Green J., Weinstein J.K., Pisarcik D.A., and Hamilton T.C. Activation of cancer-specific gene expression by the survivin promoter J. Natl. Cancer Inst. 94 2002 522 528
13. Bartke T., Pohl C., Pyrowolakis G., and Jentsch S. Dual Role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase Mol. Cell 14 2004 801 811
14. 2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity J. Cell Sci. 117 2004 4033 4042
15. Beltrami E., Plescia J., Wilkinson J.C., Duckett C.S., and Altieri D.C. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis J. Biol. Chem. 279 2004 2077 2084
16. Biggins S., and Murray A.W. The budding yeast protein kinase Ipl1/Aurora allows the absence of tension to activate the spindle checkpoint Genes Dev. 15 2001 3118 3129
17. Blanc-Brude O.P., Mesri M., Wall N.R., Plescia J., Dohi T., and Altieri D.C. Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis Clin. Cancer Res. 9 2003 2683 2692
18. Blanc-Brude O.P., Yu J., Simosa H., Conte M.S., Sessa W.C., and Altieri D.C. Inhibitor of apoptosis protein survivin regulates vascular injury Nat. Med. 8 2002 987 994
19. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M., Ricci J.E., Edris W.A., Sutherlin D.P., Green D.R., and Salvesen G.S. A unified model for apical caspase activation Mol. Cell 11 2003 529 541
20. Bolton M.A., Lan W., Powers S.E., McCleland M.L., Kuang J., and Stukenberg P.T. Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation Mol. Biol. Cell 13 2002 3064 3077
21. Buvelot S., Tatsutani S.Y., Vermaak D., and Biggins S. The budding yeast Ipl1/aurora protein kinase regulates spindle disassembly J. Cell Biol. 160 2003 329 339
22. Caldas H., Jiang Y., Holloway M.P., Fangusaro J., Mahotka C., Altura R.A., and Conway E.M. Survivin splice variants regulate the balance between proliferation and cell death Oncogene 24 2005 1994 2007
23. Cande C., Cecconi F., Dessen P., and Kroemer G. Apoptosis-inducing factor (AIF): Key to the conserved caspase-independent pathways of cell death? J. Cell Sci. 115 2002 4727 4734
24. Cande C., Vahsen N., Kouranti I., Schmitt E., Daugas E., Spahr C., Luban J., Kroemer R.T., Giordanetto F., Garrido C., Penninger J.M., and Kroemer G. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis Oncogene 23 2004 1514 1521
25. Carmena M., and Earnshaw W.C. The cellular geography of aurora kinases Nat. Rev. Mol. Cell Biol. 4 2003 842 854
26. Carvalho A., Carmena M., Sambade C., Earnshaw W.C., and Wheatley S.P. Survivin is required for stable checkpoint activation in response to loss of spindle tension in HeLa cells J. Cell Sci. 116 2003 2987 2998
27. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Dataa P., Alnemri E.S., and Shi Y. Structural basis of caspase-7 inhibition by XIAP Cell 104 2001 769 780
28. Chantalat L., Skoufias D.A., Kleman J.P., Jung B., Dideberg O., and Margolis R.L. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual α-helical extensions Mol. Cell 6 2000 183 189
29. Chauhan D., Hideshima T., Rosen S., Reed J.C., Kharbanda S., and Anderson K.C. Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells J. Biol. Chem. 276 2001 24453 24456
30. Chawla-Sarkar M., Bae S.I., Reu F.J., Jacobs B.S., Lindner D.J., and Borden E.C. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis Cell Death Differ. 11 2004 915 923
31. Cheeseman I.M., Anderson S., Jwa M., Green E.M., Kang J., Yates J.R.I., Chan C.S., Drubin D.G., and Barnes G. Phospho-regulation of kinetochore- microtubule attachments by the aurora kinase Ipl1 Cell 111 2002 163 172
32. Chen J., Jin S., Tahir S.K., Zhang H., Liu X., Sarthy A.V., McGonigal T.P., Liu Z., Rosenberg S.H., and Ng S.-C. Survivin enhances aurora-B kinase activity and localizes aurora-B in human cells J. Biol. Chem. 278 2003 486 490
33. Cohen C., Lohmann C.M., Cotsonis G., Lawson D., and Santoianni R. Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis Mod. Pathol. 16 2003 574 583
34. Conway E.M., Pollefeyt S., Cornelissen J., De Baere I., Steiner-Mosonyi M., Ong K., Baens M., Collen D., and Schuh A.C. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions Blood 95 2000 1435 1442
35. Crook N.E., Clem R.J., and Miller L.K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif J. Virol. 67 1993 2168 2174
36. Deng Y., Lin Y., and Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO Genes Dev. 16 2002 33 45
37. Dickson D.W. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: Cause or effect? J. Clin. Invest. 114 2004 23 27
38. Ditchfield C., Johnson V.L., Tighe A., Ellston R., Haworth C., Johnson T., Mortlock A., Keen N., and Taylor S.S. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and CENP-E to kinetochores J. Cell Biol. 161 2003 267 280
39. Dohi T., Beltrami E., Wall N.R., Plescia J., and Altieri D.C. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis J. Clin. Invest. 114 2004 1117 1127
40. Donepudi M., Sweeney A.M., Briand C., and Grutter M.G. Insights into the regulatory mechanism for caspase-8 activation Mol. Cell 11 2003 543 549
41. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
42. Duckett C.S., Nava V.E., Gedrich R.W., Clem R.J., Van Dongen J.L., Gilfillan M.C., Shiels H., Hardwick J.M., and Thompson C.B. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors EMBO J. 15 1996 2685 2694
43. Ekert P., Silke J., Hawkins C., Verhagen A., and Vaux D. Diablo promotes apoptosis by removing MIHA/XIAP from processed caspase 9 J. Cell Biol. 152 2001 483 490
44. Fortugno P., Wall N.R., Giodini A., O'Connor D.S., Plescia J., Padgett K.M., Tognin S., Marchisio P.C., and Altieri D.C. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function J. Cell Sci. 115 2002 575 585
45. Fraser A.G., and Evan G.I. Identification of a Drosophila melanogaster ICE/CED-3-related protease, drICE EMBO J. 16 1997 2805 2813
46. Fraser A.G., James C., Evan G.I., and Hengartner M.O. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis Curr. Biol. 9 1999 292 301
47. Frost M., Jarboe E.A., Orlicky D., Gianani R., Thompson L.C., Enomoto T., and Shroyer K.R. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma Am. J. Clin. Pathol. 117 2002 738 744
48. Gassmann R., Carvalho A., Henzing A.J., Ruchaud S., Hudson D.F., Honda R., Nigg E.A., Gerloff D.L., and Earnshaw W.C. Borealin: A novel chromosomal passenger required for stability of the bipolar spindle J. Cell Biol. 166 2004 179 191
49. Geisbrecht E.R., and Montell D.J. A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration Cell 118 2004 111 125
50. Gigoux V., L'Hoste S., Raynaud F., Camonis J., and Garbay C. Identification of aurora kinases as RasGAP Src homology 3 domain-binding proteins J. Biol. Chem. 277 2002 23742 23746
51. Giodini A., Kallio M.J., Wall N.R., Gorbsky G.J., Tognin S., Marchisio P.C., Symons M., and Altieri D.C. Regulation of microtubule stability and mitotic progression by survivin Cancer Res. 62 2002 2462 2467
52. Grogan T.M., Lippman S.M., Spier C.M., Slymen D.J., Rybski J.A., Rangel C.S., Richter L.C., and Miller T.P. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67 Blood 71 1988 1157 1160
53. Grossman D., Kim P.J., Schechner J.S., and Altieri D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting Proc. Natl. Acad. Sci. USA 98 2001 635 640
54. Guicciardi M.E., Leist M., and Gores G.J. Lysosomes in cell death Oncogene 23 2004 2881 2890
55. Hao Y., Sekine K., Kawabata A., Nakamura H., Ishioka T., Ohata H., Katayama R., Hashimoto C., Zhang X., Noda T., Tsuruo T., and Naito M. Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function Nat. Cell Biol. 6 2004 849 860
56. Harlin H., Reffey S.B., Duckett C.S., Lindsten T., and Thompson C.B. Characterization of XIAP-deficient mice Mol. Cell. Biol. 21 2001 3604 3608
57. Hauf S., Cole R.W., La Terre S., Zimmer C., Schnapp G., Walter R., Heckel A., van Meel J., Rieder C.L., and Peters J.M. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint J. Cell Biol. 161 2003 281 294
58. Hay B.A., Wassarman D.A., and Rubin G.M. Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death Cell 83 1995 1253 1262
59. Hofer-Warbinek R., Schmid J.A., Stehlik C., Binder B.R., Lipp J., and de Martin R. Activation of NF-κB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1 J. Biol. Chem. 275 2000 22064 22068
60. Hoffman W.H., Biade S., Zilfou J.T., Chen J.D., and Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 J. Biol. Chem. 277 2002 3247 3257
61. Honda R., Korner R., and Nigg E.A. Exploring the functional interactions between aurora B, INCENP, and survivin in mitosis Mol. Biol. Cell 14 2003 3325 3341
62. Huang Y., Park Y.C., Rich R.L., Segal D., Myszka D.G., and Wu H. Structural basis of caspase inhibition by XIAP. Differential roles of the linker versus the BIR domain Cell 104 2001 781 790
63. Igaki T., and Miura M. Role of Bcl-2 family members in invertebrates Biochim. Biophys. Acta 1644 2004 73 81
64. Islam A., Kageyama H., Hashizume K., Kaneko Y., and Nakagawara A. Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-β/2B Med. Pediatr. Oncol. 35 2000 550 553
65. Jiang X., Wilford C., Duensing S., Munger K., Jones G., and Jones D. Participation of survivin in mitotic and apoptotic activities of normal and tumor-derived cells J. Biol. Chem. 83 2001 342 354
66. Jiang Y., Saavedra H.I., Holloway M.P., Leone G., and Altura R.A. Aberrant regulation of survivin by the RB/E2F family of proteins J. Biol. Chem. 279 2004 40511 40520
67. Jones G., Jones D., Zhou L., Stellar H., and Chu Y. Deterin, a new inhibitor of apoptosis from Drosophila melanogaster J. Biol. Chem. 275 2000 22157 22165
68. Kallio M.J., McCleland M.L., Stukenberg P.T., and Gorbsky G.J. Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis Curr. Biol. 12 2002 900 905
69. Kami K., Doi R., Koizumi M., Toyoda E., Mori T., Ito D., Fujimoto K., Wada M., Miyatake S., and Imamura M. Survivin expression is a prognostic marker in pancreatic cancer patients Surgery 136 2004 443 448
70. Kanuka H., Sawamoto K., Inohara N., Matsuno K., Okano H., and Miura M. Control of the cell death pathway by Dapaf-1, a Drosophila Apaf-1/CED-4-related caspase activator Mol. Cell 4 1999 757 769
71. Kappler M., Bache M., Bartel F., Kotzsch M., Panian M., Wurl P., Blumke K., Schmidt H., Meye A., and Taubert H. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53 Cancer Gene Ther. 11 2004 186 193
72. Kawane K., Fukuyama H., Yoshida H., Nagase H., Ohsawa Y., Uchiyama Y., Okada K., Iida T., and Nagata S. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation Nat. Immunol. 4 2003 138 144
73. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics British J. Cancer 26 1972 239 257
74. Kim P.J., Plescia J., Clevers H., Fearon E.R., and Altieri D.C. Survivin and molecular pathogenesis of colorectal cancer Lancet 362 2003 205 209
75. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., Bronson R.T., and Ackerman S.L. The harlequin mouse mutation downregulates apoptosis-inducing factor Nature 419 2002 367 374
76. Knutsen A., Adell G., and Sun X.F. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 60 2004 149 155
77. Kobayashi K., Hatano M., Otaki M., Ogasawara T., and Tokuhisa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation Proc. Natl. Acad. Sci. USA 96 1999 1457 1462
78. Krieg A., Mahotka C., Krieg T., Grabsch H., Muller W., Takeno S., Suschek C.V., Heydthausen M., Gabbert H.E., and Gerharz C.D. Expression of different survivin variants in gastric carcinomas: First clues to a role of survivin-2B in tumour progression Br. J. Cancer 86 2002 737 743
79. Lan W., Zhang X., Kline-Smith S.L., Rosasco S.E., Barrett-Wilt G.A., Shabanowitz J., Hunt D.F., Walczak C.E., and Stukenberg P.T. Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity Curr. Biol. 14 2004 273 286
80. Lauber K., Blumenthal S.G., Waibel M., and Wesselborg S. Clearance of apoptotic cells: Getting rid of the corpses Mol. Cell 14 2004 277 287
81. Lens S.M., and Medema R.H. The survivin/Aurora B complex: Its role in coordinating tension and attachment Cell Cycle 2 2003 507 510
82. Lens S.M.A., Wolthuis R.M.F., Klompmaker R., Kauw J., Agami R., Brummelkamp T., Kops G., and Medema R.H. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension EMBO J. 22 2003 2934 2947
83. Leverson J.D., Huang H., Forsburg S.L., and Hunter T. The Schizosaccharomyces pombe aurora-related kinase Ark1 interacts with the inner centromere protein Pic1 and mediates chromosome segregation and cytokinesis Mol. Biol. Cell 13 2002 1132 1143
84. Lewis J., Burstein E., Reffey S.B., Bratton S.B., Roberts A.B., and Duckett C.S. Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis J. Biol. Chem. 279 2004 9023 9029
85. Li F. Role of survivin and its splice variants in tumorigenesis Br. J. Cancer 92 2004 212 216
86. Li F., Ackerman E.J., Bennett C.F., Rothermel A.L., Plescia J., Tognin S., Villa A., Marchisio P.C., and Altieri D.C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function Nat. Cell Biol. 1 1999 461 466
87. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
88. Li F.Z., and Altieri D.C. The cancer antiapoptosis mouse survivin gene: Characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression Cancer Res. 59 1999 3143 3151
89. Li F.Z., and Altieri D.C. Transcriptional analysis of human survivin gene expression Biochem. J. 344 1999 305 311
90. Li L.Y., Luo X., and Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria Nature 412 2001 95 99
91. Lin L.J., Zheng C.Q., Jin Y., Ma Y., Jiang W.G., and Ma T. Expression of survivin protein in human colorectal carcinogenesis World J. Gastroenterol. 9 2003 974 977
92. 2/M arrest J. Biol. Chem. 279 2004 15196 15203
93. Ling X., and Li F. Silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology Biotechniques 36 2004 456 460
94. Liu T., Brouha B., and Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells Oncogene 23 2004 39 48
95. Liu Z.H., Sun C.H., Olejniczak E.T., Meadows R.P., Betz S.F., Oost T., Herrmann J., Wu J.C., and Fesik S.W. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain Nature 408 2000 1004 1008
96. Lo Muzio L., Campisi G., Giovannelli L., Ammatuna P., Greco I., Staibano S., Pannone G., De Rosa G., Di Liberto C., and D'Angelo M. HPV DNA and survivin expression in epithelial oral carcinogenesis: A relationship? Oral Oncol. 40 2004 736 741
97. Lohr K., Moritz C., Contente A., and Dobbelstein M. p21/CDKN1A mediates negative regulation of transcription by p53 J. Biol. Chem. 278 2003 32507 32516
98. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X.D. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 94 1998 481 490
99. Luque L.E., Grape K.P., and Junker M. A highly conserved arginine is critical for the functional folding of inhibitor of apoptosis (IAP) BIR domains Biochemistry 41 2002 13663 13671
100. Mahotka C., Liebmann J., Wenzel M., Suschek C.V., Schmitt M., Gabbert H.E., and Gerharz C.D. Differential subcellular localization of functionally divergent survivin splice variants Cell Death Differ. 9 2002 1334 1342
101. Mahotka C., Wenzel M., Springer E., Gabbert H.E., and Gerharz C.D. Survivin-ΔEx3 and Survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties Cancer Res. 59 1999 6097 6102
102. Maiato H., De Luca J., Salmon E.D., and Earnshaw W.C. The dynamic kinetochore-microtubule interface J. Cell Sci. 117 2004 5461 5477
103. Martinon F., and Tschopp J. Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases Cell 117 2004 561 574
104. McKay T.R., Bell S., Tenev T., Stoll V., Lopes R., Lemoine N.R., and McNeish I.A. Pro-caspase-3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant negative mutant, survivin T34A: A combination gene therapy strategy Oncogene 22 2003 3539 3547
105. McNeish I.A., Bell S., McKay T., Tenev T., Marani M., and Lemoine N.R. Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway Exp. Cell Res. 286 2003 186 198
106. McNeish I.A., Lopes R., Bell S.J., McKay T.R., Fernandez M., Lockley M., Wheatley S.P., and Lemoine N.R. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis Exp. Cell Res. 302 2005 69 82
107. Meng H., Lu C., Mabuchi H., and Tanigawa N. Prognostic significance and different properties of survivin splicing variants in gastric cancer Cancer Lett. 216 2004 147 155
108. Mesri M., Wall N.R., Li J., Kim R.W., and Altieri D.C. Cancer gene therapy using a survivin mutant adenovirus J. Clin. Invest. 108 2001 981 990
109. Mirza A., McGuirk M., Hockenberry T.N., Wu Q., Ashar H., Black S., Wen S.F., Wang L.Q., Kirschmeier P., Bishop W.R., Nielsen L.L., Pickett C.B., and Liu S.X. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway Oncogene 21 2002 2613 2622
110. Morishita J., Matsusaka T., Goshima G., Nakamura T., Tatebe H., and Yanagida M. Bir1/Cut17 moving from chromosome to spindle upon the loss of cohesion is required for condensation, spindle elongation and repair Genes Cells 6 2001 743 763
111. Muchmore S.W., Chen J., Jakob C., Zakula D., Matayoshi E.D., Wu W., Zhang H.C., Li F.Z., Ng S.C., and Altieri D.C. Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin Mol. Cell 6 2000 173 182
112. Murata-Hori M., and Wang Y. The kinase activity of Aurora B is required for kinetochore-microtubule interactions during mitosis Curr. Biol. 12 2002 894 899
113. Murphy C.R., Sabel J.L., Sandler A.D., and Dagle J.M. Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis Dev. Dyn. 225 2002 597 601
114. cdc2 phosphorylation of survivin Proc. Natl. Acad. Sci. USA 97 2000 13103 13107
115. Ohi R., Coughlin M.L., Lane W.S., and Mitchison T.J. An inner centromere protein that stimulates the microtubule depolymerising activity of a KinI kinase Dev. Cell 5 2003 309 321
116. Okada H., Bakal C., Shahinian A., Elia A., Wakeham A., Suh W.-K., Duncan G.S., Ciofani M., Rottapel R., Zuniga-Pflucker J.C., and Mak T.W. Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death J. Exp. Med. 199 2004 399 410
117. Okada H., Suh W.-K., Jin J., Woo M., Du C., Elia A., Duncan G.S., Wakeham A., Itie A., Lowe S.W., Wang X., and Mak T.W. Generation and characterization of Smac/DIABLO-deficient mice Mol. Cell. Biol. 22 2002 3509 3517
118. Olie R.A., Simoes-Wust A.P., Baumann B., Leech S.H., Fabbro D., Stahel R.A., and Zangemeister-Wittke U. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy Cancer Res. 60 2000 2805 2809
119. Otto K., Andersen M.H., Eggert A., Keikavoussi P., Pedersen L.O., Rath J.C., Bock M., Brocker E.B., Straten P.T., Kampgen E., and Becker J.C. Lack of toxicity of therapy-induced T cell responses against the universal tumor antigen survivin Vaccine 23 2005 884 889
120. Pardo O.E., Lesay A., Arcaro A., Lopes R., Ng B.L., Warne P.H., McNeish I.A., Tetley T.D., Lemoine N.R., Mehmet H., Seckl M.J., and Downward J. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells Mol. Cell. Biol. 23 2003 7600 7610
121. Pennati M., Binda M., Colella G., Zoppe M., Folini M., Vignati S., Valentini A., Citti L., De Cesare M., Pratesi G., Giacca M., Daidone M.G., and Zaffaroni N. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells Oncogene 23 2004 386 394
122. Petersen J., and Hagan I.M. S. pombe aurora kinase/survivin is required for chromosome condensation and the spindle checkpoint attachment response Curr. Biol. 13 2003 590 597
123. Rajagopalan S., and Balasubramanian M.K. S. pombe Pbh1p: An inhibitor of apoptosis domain containing protein is essential for chromosome segregation FEBS Letts. 460 1999 187 190
124. Rajagopalan S., and Balasubramanian M.K. Schizosaccharomyces pombe Bir1p, a nuclear protein that localizes to kinetochores and the spindle midzone, is essential for chromosome condensation and spindle elongation during mitosis Genetics 160 2002 445 456
125. Reed J.C. Dysregulation of apoptosis in cancer J. Clin. Oncol. 17 1999 2941 2953
126. Reed J.C. The Survivin saga goes in vivo J. Clin. Invest. 108 2001 965 969
127. Reffey S.B., Wurthner J.U., Parks W.T., Roberts A.B., and Duckett C.S. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling J. Biol. Chem. 276 2001 26542 26549
128. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., Liddington R.C., and Salvesen G.S. Structural basis for the inhibition of caspase-3 by XIAP Cell 104 2001 791 800
129. Rodriguez J.A., Span S.W., Ferreira C.G.M., Kruyt F.A.E., and Giaccone G. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin Exp. Cell Res. 275 2002 44 53
130. Romano A., Guse A., Krascenicova I., Schnabel H., Schnabel R., and Glotzer M. CSC1: A subunit of the aurora B kinase complex that binds to the survivin-like protein BIR-1 and the Incenp-like protein ICP-1 J. Cell Biol. 161 2003 229 236
131. Samejima I., Matsumoto T., Nakeseko Y., Beach D., and Yanagida M. Identification of seven new cut genes involved in Schizosaccharomyces pombe mitosis J. Cell Sci. 105 1993 135 143
132. Sampath S.C., Ohi R., Leismann O., Salic A., Pozniakovski A., and Funabiki H. The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly Cell 118 2004 187 202
133. Sanna M.G., Correia J.d.S., Ducrey O., Lee J., Nomoto K., Schrantz N., Deveraux Q.L., and Ulevitch R.J. IAP suppression of apoptosis involves distinct mechanisms: The TAK1/JNK1 signaling cascade and caspase inhibition Mol. Cell. Biol. 22 2002 1754 1766
134. Sanna M.G., Duckett C.S., Richter B.W., Thompson C.B., and Ulevitch R.J. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP Proc. Natl. Acad. Sci. USA 95 1998 6015 6020
135. Shi Y.G. A structural view of mitochondria-mediated apoptosis Nat. Struct. Biol. 8 2001 394 401
136. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC Nature 399 1999 483 487
137. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., and Oh B.H. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 Biochemistry 40 2001 1117 1123
138. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P.W., Srinivasula S.M., Alnemri E.S., Fairman R., and Shi Y. Mechanism of XIAP-mediated inhibition of caspase-9 Mol. Cell 11 2003 519 527
139. Silke J., and Vaux D. Two kinds of BIR-containing protein: Inhibitors of apoptosis, or required for mitosis J. Cell Sci. 114 2001 1821 1827
140. Skoufias D.A., Mollinari C., Lacroix F.B., and Margolis R.L. Human survivin is a kinetochore-associated passenger protein J. Cell Biol. 151 2000 1575 1581
141. Song K.-H., Kim T.-M., Kim H.-J., Kim J.-W., Kim H.-H., Kwon H.-B., Kim W.S., and Choi H.-S. Molecular cloning and characterization of a novel inhibitor of apoptosis protein from Xenopus laevis Biochem. Biophys. Res. Commun. 301 2003 236 242
142. Song Z., Liu S., He H., Hoti N., Wang Y., Feng S., and Wu M. A single amino acid change (Asp53-Ala53) converts survivin from anti-apoptotic to pro-apoptotic Mol. Biol. Cell 15 2004 1287 1296
143. Speliotes E.K., Uren A., Vaux D., and Horvitz H.R. The survivin-like C. elegans BIR-1 protein acts with the aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone Mol. Cell 6 2000 211 223
144. Stehlik C., de Martin R., Kumabashiri I., Schmid J.A., Binder B.R., and Lipp J. Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis J. Exp. Med. 188 1998 211 216
145. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., Ellerby L.M., Bredesen D., Freeze H., Abrahamson M., Bromme D., Krajewski S., Reed J.C., Yin X.M., Turk V., and Salvesen G.S. Lysosomal protease pathways to apoptosis: Cleavage of BID, not pro-caspases, is the most likely route J. Biol. Chem. 276 2001 3149 3157
146. Sun C., Nettesheim D., Liu Z., and Olejniczak E.T. Solution structure of human survivin and its binding interface with Smac/DIABLO Biochemistry 44 2005 11 17
147. Susin S.A., Daugas E., Ravagnan L., Samejima K., Zamzami N., Loeffler M., Costantini P., Ferri K.F., Irinopoulou T., Prevost M.-C., Brothers G., Mak T.W., Penninger J., Earnshaw W.C., and Kroemer G. Two distinct pathways leading to nuclear apoptosis J. Exp. Med. 192 2000 571 580
148. Suzuki Y., Nakabayashi Y., and Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death Proc. Natl. Acad. Sci. USA 98 2001 8662 8667
149. Tamm I., Richter S., Oltersdorf D., Creutzig U., Harbott J., Scholz F., Karawajew L., Ludwig W.D., and Wuchter C. High expression levels of X-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia Clin. Cancer Res. 10 2004 3737 3744
150. Tamm I., Wang Y., Sausville E., Scudiero D., Vigna N., Oltersdorf T., and Reed J. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases and anticancer drugs Cancer Res. 58 1998 5315 5320
151. Tanaka T.U., Rachidi N., Janke C., Pereira G., Galova M., Scheibel E., Stark M.J.R., and Nasmyth K. Evidence that the Ipl1-Sli15 (aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections Cell 108 2002 317 329
152. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., and Lin A. Inhibition of JNK activation through NF-κB target genes Nature 414 2001 313 317
153. Temme A., Rieger M., Reber F., Lindemann D., Weigle B., Diestelkoetter-Bachert P., Ehninger G., Tatsuka M., Terada Y., and Rieber E.P. Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell Mol. Biol. Cell 14 2003 78 92
154. Tenev T., Zachariou A., Wilson R., Ditzel M., and Meier P. IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms Nat. Cell Biol. 7 2005 70 77
155. Thome M., and Tschopp J. Regulation of lymphocyte proliferation and death by FLIP Nat. Rev. Immunol. 1 2001 50 58
156. Thornberry N., and Lazebnik Y. Caspases: Enemies within Science 281 1998 1312 1316
157. Turk B., Turk D., and Turk V. Lysosomal cysteine proteases: More than scavengers Biochim. Biophys. Acta 1477 2000 98 111
158. Uchida H., Tanaka T., Sasaki K., Kato K., Dehari H., Ito Y., Kobune M., Miyagishi M., Taira K., Tahara H., and Hamada H. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo Mol. Ther. 10 2004 162 171
159. Uetake Y., and Sluder G. Cell cycle progression after cleavage failure: Mammalian somatic cells do not possess a "tetraploidy checkpoint." J. Cell Biol. 165 2004 609 615
160. Uren A.G., Beilharz T., O'Connell M.J., Bugg S.J., Van Driel R., Vaux D.L., and Lithgow T. Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division Proc. Natl. Acad. Sci. USA 96 1999 10170 10175
161. Uren A.G., Wong L., Pakusch M., Fowler K.J., Burrows F.J., Vaux D.L., and Choo K.H.A. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype Curr. Biol. 10 2000 1319 1328
162. Vagnarelli P., and Earnshaw W.C. Chromosomal passengers: The four-dimensional regulation of mitotic events Chromosoma 113 2004 211 222
163. Velculescu V.E., Madden S.L., Zhang L., Lash A.E., Yu J., Rago C., Lal A., Wang C.J., Beaudry G.A., Ciriello K.M., Cook B.P., Dufault M.R., Ferguson A.T., Gao Y., He T.C., Hermeking H., Hiraldo S.K., Hwang P.M., Lopez M.A., Luderer H.F., Mathews B., Petroziello J.M., Polyak K., Zawel L., and Kinzler K.W. Analysis of human transcriptomes Nat. Genet. 4 1999 387 388
164. Verdecia M., Huang H.-K., Dutil E., Kaiser D., Hunter T., and Noel J. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement Nat. Struct. Biol. 7 2000 602 608
165. Verhagen A., Ekert P., Pakusch M., Silke J., Connolly L., Reid G., Moritz R., Simpson R., and Vaux D. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins Cell 102 2000 43 53
166. Verhagen A.M., Coulson E.J., and Vaux D.L. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs Genome Biol. 2 2001 3009.1 3009.10
167. Vucic D., Deshayes K., Ackerly H., Pisabarro M.T., Kadkhodayan S., Fairbrother W.J., and Dixit V.M. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) J. Biol. Chem. 277 2002 12275 12279
168. Wall N.R., O'Connor D.S., Plescia J., Pommier Y., and Altieri D.C. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis Cancer Res. 63 2003 230 235
169. Wang H.-W., Sharp T.V., Koumi A., Koentges G., and Boshoff C. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin EMBO J. 21 2002 2602 2615
170. Wang Z., Fukuda S., and Pelus L. Survivin regulates the p53 tumor suppressor gene family Oncogene 23 2004 8146 8153
171. Wheatley S.P., Carvalho A., Vagnarelli P., and Earnshaw W.C. INCENP is required for proper targeting of survivin to the centromeres and the anaphase spindle during mitosis Curr. Biol. 11 2001 886 890
172. Wheatley S.P., Henzing A.J., Dodson H., Khaled W., and Earnshaw W.C. Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to INCENP in vivo J. Biol. Chem. 279 2004 5655 5660
173. Wilkinson J.C., Cepero E., Boise L.H., and Duckett C.S. Upstream regulatory role for XIAP in receptor-mediated apoptosis Mol. Cell. Biol. 24 2004 7003 7014
174. Wu G., Chai J.J., Suber T.L., Wu J.W., Du C.Y., Wang X.D., and Shi Y.G. Structural basis of IAP recognition by Smac/DIABLO Nature 408 2000 1008 1012
175. Wu J., Ling X., Pan D., Apontes P., Song L., Liang P., Altieri D.C., Beerman T., and Li F. Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence selective DNA-binding antitumor agent, hedamycin: Evidence of survivin downregulation associated with drug sensitivity J. Biol. Chem. 280 2005 9745 9751
176. Xu X., Gerard A., Huang B., Anderson D., Payan D., and Luo Y. Detection of programmed cell death using fluorescence energy transfer Nucleic Acids Res. 26 1998 2034 2035
177. Xu Y., Fang F., Ludewig G., Jones G., and Jones D. A mutation found in the promoter region of the human survivin gene is correlated with overexpression of survivin in cancer cells DNA Cell Biol. 9 2004 527 537
178. Yamagiwa Y., Marienfeld C., Meng F., Holcik M., and Patel T. Translational regulation of X-linked inhibitor of apoptosis protein by interleukin-6: A novel mechanism of tumor cell survival Cancer Res. 64 2004 1293 1298
179. ARF gene transfer in human mesothelioma cells J. Natl. Cancer Inst. 92 2000 636 641
180. Yang D., Welm A., and Bishop J.M. Cell division and cell survival in the absence of survivin Proc. Natl. Acad. Sci. USA 101 2004 15100 15105
181. Yang L., Cao Z., Li F., Post D.E., Van Meir E.G., Zhong H., and Wood W.C. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia Gene Ther. 11 2004 1215 1223
182. Yang X.-H., Sladek T.L., Liu X., Butler B.R., Froelich C.J., and Thor A.D. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis Cancer Res. 61 2001 348 354
183. Yoon H., and Carbon J. Participation of Bir1p, a member of the inhibitor of apoptosis family, in yeast chromosome segregation events Proc. Natl. Acad. Sci. USA 96 1999 13208 13213
184. Yu J., Zhang H., Gu J., Lin S., Li J., Lu W., Wang Y., and Zhu J. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma BMC Cancer 4 2004 65
185. Zachariou A., Tenev T., Goyal L., Agapite J., Steller H., and Meier P. IAP-antagonists exhibit non-redundant modes of action through differential DIAP1 binding EMBO J. 22 2003 6642 6652
186. Zaffaroni N., Pennati M., Colella G., Perego P., Supino R., Gatti L., Pilotti S., Zunino F., and Daidone M.G. Expression of the anti-apoptotic gene survivin correlates with Taxol resistance in human ovarian cancer Cell. Mol. Life Sci. 59 2002 1406 1412
187. Zhang Y., Nagata Y., Yu G., Nguyen H.G., Jones M.R., Toselli P., Jackson C.W., Tatsuka M., Todokoro K., and Ravid K. Aberrant quantity and localization of aurora-B/AIM1 and survivin during megakarocyte polyploidization and the consequences of aurora-B/AIM1-deregulated expression Blood 103 2004 3717 3726
188. Zhao J., Tenev T., Martins L.M., Downward J., and Lemoine N.R. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner J. Cell Sci. 113 2000 4363 4371
189. Zhao M., Antunes F., Eaton J.W., and Brunk U.T. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis Eur. J. Biochem. 270 2003 3778 3786
190. Zhou J., O'Brate A., Zelnak A., and Giannakakou P. Survivin deregulation in β-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to Taxol Cancer Res. 64 2004 8708 8714
191. Zhou M., Gu L., Li F., Zhu Y., Woods W.G., and Findley H.W. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells J. Pharmacol. Exp. Ther. 303 2002 124 131
192. Zhu Z.B., Makhija S.K., Lu B., Wang M., Kaliberova L., Liu B., Rivera A.A., Nettelbeck D.M., Mahasreshti P.J., Leath C.A., Barker S., Yamaoto M., Li F., Alvarez R.D., and Curiel D.T. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter Cancer Gene Ther. 11 2004 256 262